Pathogen-derived vaccine antigens

Pathogen-derived vaccine antigens are molecular structures, typically proteins, glycoproteins, or polysaccharides, derived from infectious agents such as viruses, bacteria, or parasites. These antigens serve as the primary components of vaccines, designed to be recognized by the host's immune system to elicit a protective immune response without causing the disease itself (National Institutes of Health, 2023). Upon administration, these antigens are captured by professional antigen-presenting cells, such as dendritic cells, and presented to B and T lymphocytes (Janeway's Immunobiology, 2017). This process leads to the development of immunological memory, involving the production of high-affinity antibodies and long-lived memory cells (Centers for Disease Control and Prevention, 2022). This memory ensures that if the individual is later exposed to the actual pathogen, the immune system can mount a rapid and effective defense to neutralize the threat. Modern vaccinology employs various forms of these antigens, including inactivated whole pathogens, purified subunits, or genetic instructions like mRNA that cause the host's own cells to produce the antigen (World Health Organization, 2021). The selection of an appropriate antigen is critical, as it must contain epitopes that are both immunogenic and conserved across different strains of the pathogen. Their role is central to global public health efforts in preventing infectious diseases, reducing morbidity, and managing pandemic outbreaks.

Other names

Vaccine antigensMicrobial antigensImmunogensProtective antigensVaccine immunogens

Vaccine antigens work by being processed and presented by antigen-presenting cells (APCs) via MHC molecules to T-cells and B-cells, thereby inducing a specific adaptive immune response including the production of neutralizing antibodies and memory cells.